Relmada Therapeutics
RLMD
RLMD
80 hedge funds and large institutions have $298M invested in Relmada Therapeutics in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7.86% less ownership
Funds ownership: 65.19% → 57.33% (-7.9%)
24% less capital invested
Capital invested by funds: $393M → $298M (-$94.5M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
80
Holding in Top 10
2
Calls
$6.72M
Puts
$17K
Top Buyers
| 1 | +$8.99M | |
| 2 | +$2.75M | |
| 3 | +$1.6M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$802K |
| 5 |
Millennium Management
New York
|
+$800K |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$11.3M | |
| 3 | -$9.62M | |
| 4 |
TA
Tiedemann Advisors
New York
|
-$6.87M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.03M |